Wall, Jonathan S.
Williams, Angela
Richey, Tina
Stuckey, Alan
Wooliver, Craig
Christopher Scott, J.
Donnell, Robert
Martin, Emily B.
Kennel, Stephen J.
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK079984)
Molecular Imaging and Translational Research Program
University of Tennessee Medical Center Department of Medicine
Article History
First Online: 22 February 2017
Compliance with Ethical Standards
:
: JSW and SJK are inventors on patent applications that describe the use of polybasic peptides for the detection and treatment of amyloidosis. JSW, TR, AS, EBM, and SJK are founders and co-owners of Solex, LLC that sub-licensed intellectual property related to amyloid reactive peptides.